Andrew Rees - 03 Nov 2026 Form 4 Insider Report for Crocs, Inc. (CROX)

SEC form
4
Accepted by SEC
05 Nov 2026, 16:37:48 UTC
Prior SEC filing
11 Aug 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Andrew Rees filed Form 4 for Crocs, Inc. (CROX) on 05 Nov 2026.

Key facts

  • This page summarizes Andrew Rees's Form 4 filing for Crocs, Inc. (CROX).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Nov 2026, 16:37.

Change

  • Previous filing in this sequence was filed on 11 Aug 2026.
  • Current net transaction value: -$6,115,595.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001609901 Primary reporting owner

Rees Andrew

Relationship
Chief Executive Officer, Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CROX transaction

Common Stock

Sale

Transaction value
-$2,747,870
Shares
-18,049
Change %
-2.5%
Price
$152.24
Shares after
695,244
Date
03 Nov 2026
Ownership
By Trust
Footnotes
F1, F2
CROX transaction

Common Stock

Sale

Transaction value
-$2,644,202
Shares
-17,251
Change %
-2.5%
Price
$153.28
Shares after
677,993
Date
03 Nov 2026
Ownership
By Trust
Footnotes
F2, F3
CROX transaction

Common Stock

Sale

Transaction value
-$723,523
Shares
-4,700
Change %
-0.69%
Price
$153.94
Shares after
673,293
Date
03 Nov 2026
Ownership
By Trust
Footnotes
F2, F4
CROX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
570,179
Date
03 Nov 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.67 - $152.66, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.

Footnote F2

The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.67 to $153.57, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.78 to $154.08, inclusive.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .